Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Marinov

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Marine Pollution Bulletin|April 29, 2006
A 3D hydrodynamic fate and transport model for herbicides in Sacca di Goro coastal lagoon (Northern Adriatic)R Carafa, D Marinov, S Dueri, et al.
The British Journal of Oral & Maxillofacial Surgery|August 26, 2015
Clinical applicability of robot-guided contact-free laser osteotomy in cranio-maxillo-facial surgery: in-vitro simulation and in-vivo surgery in minipig mandiblesK-W Baek, W Deibel, D Marinov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Follistatin-like protein-1 is a novel proinflammatory moleculeTakako Miyamae, Anthony D Marinov, Dawn Sowders, et al.
Arthritis and Rheumatism|May 28, 2010
Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritisDavid C Wilson, Anthony D Marinov, Harry C Blair, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cellsYury Chaly, Harry C Blair, Sonja M Smith, et al.
Folia Medica|July 30, 2011
A model of experimental acute hematogenous pyelonephritis in the ratStoyanka Tancheva, Stefka V Valcheva-Kuzmanova, Radko Zl Radev, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus ModelAnthony D Marinov, Haowei Wang, Sheldon I Bastacky, et al.
ACS Nano|March 17, 2023
<i>Ex Situ</i> Characterization of 1T/2H MoS<sub>2</sub> and Their Carbon Composites for Energy Applications, a ReviewAlexandar D Marinov, Laura Bravo Priegue, Ami R Shah, et al.
The Journal of Experimental Medicine|February 24, 2023
Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in miceKevin M Nickerson, Shuchi Smita, Kenneth B Hoehn, et al.
Arthritis and Rheumatism|March 12, 2010
Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritisMargalit E Rosenkranz, David C Wilson, Anthony D Marinov, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Marine Pollution Bulletin|April 29, 2006
A 3D hydrodynamic fate and transport model for herbicides in Sacca di Goro coastal lagoon (Northern Adriatic)R Carafa, D Marinov, S Dueri, et al.
The British Journal of Oral & Maxillofacial Surgery|August 26, 2015
Clinical applicability of robot-guided contact-free laser osteotomy in cranio-maxillo-facial surgery: in-vitro simulation and in-vivo surgery in minipig mandiblesK-W Baek, W Deibel, D Marinov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 20, 2006
Follistatin-like protein-1 is a novel proinflammatory moleculeTakako Miyamae, Anthony D Marinov, Dawn Sowders, et al.
Arthritis and Rheumatism|May 28, 2010
Follistatin-like protein 1 is a mesenchyme-derived inflammatory protein and may represent a biomarker for systemic-onset juvenile rheumatoid arthritisDavid C Wilson, Anthony D Marinov, Harry C Blair, et al.
Annals of the Rheumatic Diseases|March 20, 2014
Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cellsYury Chaly, Harry C Blair, Sonja M Smith, et al.
Folia Medica|July 30, 2011
A model of experimental acute hematogenous pyelonephritis in the ratStoyanka Tancheva, Stefka V Valcheva-Kuzmanova, Radko Zl Radev, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 5, 2020
The Type II Anti-CD20 Antibody Obinutuzumab (GA101) Is More Effective Than Rituximab at Depleting B Cells and Treating Disease in a Murine Lupus ModelAnthony D Marinov, Haowei Wang, Sheldon I Bastacky, et al.
ACS Nano|March 17, 2023
<i>Ex Situ</i> Characterization of 1T/2H MoS<sub>2</sub> and Their Carbon Composites for Energy Applications, a ReviewAlexandar D Marinov, Laura Bravo Priegue, Ami R Shah, et al.
The Journal of Experimental Medicine|February 24, 2023
Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in miceKevin M Nickerson, Shuchi Smita, Kenneth B Hoehn, et al.
Arthritis and Rheumatism|March 12, 2010
Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritisMargalit E Rosenkranz, David C Wilson, Anthony D Marinov, et al.
Pageof 3